Vote on the Top Cancer Advances of the Decade
We want to hear from you about what you think were the top cancer advances of the last 10 years.
Cancer treatment looks extraordinarily different than it did 10 years ago. From immunotherapy and CAR-T cell therapy to molecular profiling leading to more personalized treatment options, the field of oncology has definitely improved in the last decade, leading to better outcomes for patients across nearly all tumor types.
We want to hear what you thought was the biggest cancer breakthrough of the decade. Visit our survey to share your thoughts, or email editor@oncnursingnews.com
Some highlights include:
- James Allison, PhD, and Tasuku Honjo, MD, PhD, win the Nobel Prize in Physiology or Medicine for their work in immunotherapy
- Tisagenlecleucel (Kymriah) was the first CART cell therapy approved
- HPV vaccine drastically reduces cervical and other precancers across the United States
- Checkpoint inhibitors approved based on cancer's molecular makeup (MSIH status) instead of tumor location
- Nextgeneration sequencing becomes commonplace, leading to more personalized care and improved outcomes
- NCI's Lung Cancer Screening Trial shows that CT screening can reduce lung cancer deaths by 20% in heavy smokers
- The first cancer vaccine is approved (sipuleucelT) for prostate cancer
As cancer care continues to advance, the role of the oncology nurse will be paramount — and much has changed in the field over the past year. Read about the top nursing stories of 2019.
Dual Checkpoint Inhibition Increases Response Rates, Adverse Effects in Melanoma
April 19th 2024Patients with high-risk resectable melanoma treated with ipilimumab plus nivolumab had increased response rates compared with anti-PD1 monotherapy, though it was also associated with increased immune-related adverse effects.
